Kyle Hawkins, PA
Physician Assistant · Iowa City, IANPI 1396304267
Payments from drug & device makers
What this record shows
This record is dominated by grants: $37,500 of the $42,310 with a category attached, or 88.6%. Boston Scientific accounts for 89.1% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2021 at $39,570 and has fallen 97.7% since, to $924 in 2025. Among physician assistant clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $180.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$38K
- Endo Pharmaceuticals Inc.$1K
- Pfizer$703
- AbbVie$541
- Teva Pharmaceuticals USA, Inc.$319
- Novo Nordisk$229
- plus $2K from 28 others
What the payments were for
- Consulting fees$1,0803%
- Grants$37,50089%
- Food & beverage$3,6429%
- Education$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 7 | $37,702 |
| Endo Pharmaceuticals Inc. | 2 | $1,175 |
| Pfizer | 63 | $703 |
| AbbVie | 34 | $541 |
| Teva Pharmaceuticals USA, Inc. | 17 | $319 |
| Novo Nordisk | 12 | $229 |
| Lilly USA, LLC | 13 | $198 |
| Otsuka America Pharmaceutical, Inc. | 7 | $162 |
| Amgen | 11 | $159 |
| Exact Sciences | 8 | $136 |
| Boehringer Ingelheim | 9 | $133 |
| AstraZeneca | 7 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Mylan Specialty L.p. | 6 | $84 |
| Bayer | 4 | $73 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Johnson & Johnson | 3 | $45 |
| Viatris Specialty LLC | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Alkermes, Inc. | 1 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Dexcom, Inc. | 1 | $26 |
| Esperion Therapeutics, Inc. | 2 | $25 |
| Seqirus USA Inc | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| GSK | 1 | $20 |
| Harmony Biosciences LLC | 1 | $17 |
| Novartis | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$37,500
- XIAFLEX$1,080
How this compares
$42,310 in reported general payments places this provider in the 95th percentile of 1,140 physician assistant providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $30,137 |
| RybelsusSemaglutide | 18 | $27,774 |
| Tresiba Flextouch U-100Insulin Degludec | 56 | $18,121 |
| XareltoRivaroxaban | 16 | $16,677 |
| EliquisApixaban | 17 | $14,942 |
| Repatha SureclickEvolocumab | 12 | $10,846 |
| JardianceEmpagliflozin | 12 | $9,684 |
| FarxigaDapagliflozin Propanediol | 14 | $8,909 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,894 |
| LumiganBimatoprost | 16 | $4,369 |
| Potassium Chloride | 84 | $2,156 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $999 |
| Bumetanide | 44 | $926 |
| Amlodipine Besylate | 68 | $852 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $798 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $229 | $57,91149 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $120 | $16,80326 claims |
| Johnson & JohnsonXarelto | $45 | $16,67716 claims |
| PfizerEliquis | $703 | $14,94217 claims |
| Boehringer IngelheimJardiance | $133 | $9,68412 claims |
| AbbVieLumigan | $541 | $4,36916 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $11 | $69493 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,140 physician assistant providers in Iowa.
Other physician assistant in Iowa City
- Andrew MetzgerIowa City$37K
- Myrl HolidaIowa City$37K
- Courtney SeffkerIowa City$5K
- Elizabeth CooperIowa City$4K
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
- Michon LeddyClive$73K
- Kelly MerchieDavenport$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.